- Home
- Products
- Customized ADCs
- CD70
- Anti-CD70 (clone h1F6)-β-glucuronide-doxorubicin ADC
Anti-CD70 (clone h1F6)-β-glucuronide-doxorubicin ADC (CAT#: ADC-W-376)
This ADC product is comprised of an anti-CD70 monoclonal antibody (clone h1F6) conjugated via a β-glucuronide linker to a doxorubicin . The doxorubicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, doxorubicin binds to DNA, causes DNA damage.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Antibody clone #
- h1F6
- Name
- CD70
- Alternative Names
- CD70; CD70 molecule; CD27L; CD27LG; TNFSF7; CD70 antigen; CD27-L; CD27 ligand; Ki-24 antigen; surface antigen CD70; tumor necrosis factor ligand superfamily member 7; tumor necrosis factor (ligand) superfamily, member 7;
- Target Entrez Gene ID
- 970
- Target UniProt ID
- P32970
- Overview
- The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF27/CD27. It is a surface antigen on activated, but not on resting, T and B lymphocytes. It induces proliferation of costimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. This cytokine is also reported to play a role in regulating B-cell activation, cytotoxic function of natural killer cells, and immunoglobulin sythesis.
- Overview
- Humanized Anti-CD70 lgG1 Antibody, clone # h1f6
- Clone #
- h1F6
- Species Reactivity
- Human
- Name
- β-glucuronide linker
- Description
- β-Glucuronide linkers belong to Enzymatically cleavable linkers, which have expected stability and provide facile release of the active drug. The cleavage of the β-glucuronide glycosidic bond relies on lysosomal enzyme β-glucuronidase, and this enzyme is abundantly present within lysosomes and is overexpressed in some tumor types, while the enzyme activity outside cells is low.
- Name
- doxorubicin
- Description
- Doxorubicin is the generic name for the trade name drug, Adriamycin®, as well as, Rubex®, which is a type of anti-cancer chemotherapy drug called an anthracycline. Doxorubicin works by blocking an enzyme called TopoisomeraseⅡthat cancer cells need to divide and grow.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD33 (h2H12ec)-Mc-VC-SGD-1882 ADC (CAT#: ADC-W-492)
- Anti-CD33 (Gemtuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-2542)
- Anti-CD200 (Samalizumab)-MC-MMAF ADC (CAT#: ADC-W-790)
- Anti-CD27 (Varlilumab)-SPDB-DM4 ADC (CAT#: ADC-W-2223)
- Anti-MET (Emibetuzumab)-SMCC-DM1 ADC (CAT#: ADC-W-2372)
- Anti-IL6 (Sirukumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1410)
- Anti-CMV (Sevirumab)-SMCC-DM1 ADC (CAT#: ADC-W-1976)
- Anti-MET (Emibetuzumab)-MC-MMAF ADC (CAT#: ADC-W-2374)
- Anti-SOST (Romosozumab)-SMCC-DM1 ADC (CAT#: ADC-W-1772)
- Anti-MUC1 (clone ch3A5)-Mc-MMAF ADC (CAT#: ADC-W-240)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-376. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-W-451 | Anti-CD70 (clone 1F6)-Mc-VC-PABC-MMAF ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAF (Monomethyl auristatin F) |
ADC-W-953 | Anti-CD70 (Vorsetuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
ADC-W-487 | Anti-CD70-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-446 | Anti-CD70 (clone h1F6)-Mc-VC-PBD ADC | mc-VC (maleimidocaproyl-valine-citrulline) | pyrrolobenzodiazepine (PBD) dimers |
ADC-W-954 | Anti-CD70 (Vorsetuzumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
CAT# | Product Name | Linker | Payload |
ADC-W-353 | Anti-TNFRSF8 (cCA10)-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC | β-glucuronide linker | doxorubicin propyloxazoline (DPO) |
ADC-W-375 | Anti-CD70 (clone h1F6)-β-glucuronide-MMAF ADC | β-glucuronide linker | MMAF (Monomethyl auristatin F) |
ADC-W-349 | Anti-TNFRSF8 (CA10)-β-glucuronide-Camptothecin Analog ADC | β-glucuronide linker | Camptothecin Analog |
ADC-W-372 | Anti-CD70 (clone h1F6)-β-glucuronide-Camptothecin Analog ADC | β-glucuronide linker | Camptothecin Analog |
ADC-W-350 | Anti-TNFRSF8 (CA10)-β-glucuronide-CBI Minor Groove Binder ADC | β-glucuronide linker | CBI Minor Groove Binder |
CAT# | Product Name | Linker | Payload |
ADC-W-571 | Anti-ERBB2 (Trastuzumab)-DOX ADC | thiomaleamicacids-p-aminobenzyloxycarbonyl | doxorubicin |
ADC-W-502 | Anti-EGFR-SMCC-Dox ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | Doxorubicin |
ADC-W-581 | Anti-EpCAM (MOC31)-hydrazone-Doxorubicin ADC | acid-cleavable hydrazone linker | doxorubicin |
ADC-W-412 | Anti-ERBB2 (Trastuzumab)-NGM-doxorubicin ADC | NGM | doxorubicin |
ADC-W-378 | Anti-CD74-hindered disulfide-Doxorubicin ADC | hindered disulfide | doxorubicin |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.